Sarepta will resume gene therapy shipments after FDA review of recent patient death
The Food and Drug Administration said it recommended lifting the hold for young patients with Duchenne's muscular dystrophy who are still able to walk. Regulators had requested the pause after the deaths of two older teenagers who were taking the therapy. The FDA also said in a statement it determined that a recently reported death of an 8-year-old boy was unrelated to the therapy.
Company shares surged more than 16% after the announcement to $13.86 in afterhours trading. The jump is the latest in a series of drastic stock movements triggered by changing fortunes for the company's best-selling product.
Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects boys and young men, resulting in early death. It received accelerated approval in 2023 for a narrow range of young patients and was expanded last year for use in older patients, including those who can no longer walk.
The FDA decision Monday 'significantly improves Elevidys' sales outlook in the near-term,' Jefferies analyst Andrew Tsai told investors, in a note after the announcement. 'The street will feel relieved about the situation, suggesting meaningful stock upside potential.'
Sarepta's therapy has been under scrutiny from regulators after two teenage boys died earlier this year from acute liver injury, a known side effect of the treatment. The FDA then requested a pause in shipments of the drug after the death of a third patient taking a different Sarepta therapy.
FDA officials have suggested the company will need to provide new study data on safety to resume Elevidys' use in older patients.
'The FDA will continue to work with the sponsor regarding non-ambulatory patients, which remains subject to a voluntary hold, following two deaths,' FDA said in its statement.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
2 hours ago
- Toronto Star
Newly promoted Ligue 1 side Paris FC signs striker Geubbels from St. Gallen
PARIS (AP) — Newly promoted Ligue 1 side Paris FC signed striker Willem Geubbels from Swiss team St. Gallen on a five-year contract on Sunday. Paris FC announced the signing with a video posted on X. No transfer fee was given but French sports daily L'Équipe said Geubbels cost 9 million euros ($10.5 million) with a further 2.5 million euros in eventual bonuses.
Winnipeg Free Press
2 hours ago
- Winnipeg Free Press
Newly promoted Ligue 1 side Paris FC signs striker Geubbels from St. Gallen
PARIS (AP) — Newly promoted Ligue 1 side Paris FC signed striker Willem Geubbels from Swiss team St. Gallen on a five-year contract on Sunday. Paris FC announced the signing with a video posted on X. No transfer fee was given but French sports daily L'Équipe said Geubbels cost 9 million euros ($10.5 million) with a further 2.5 million euros in eventual bonuses. The 24-year-old Geubbels came through Lyon's famed youth academy but hardly played for the club before joining Monaco. He scored one league goal there and two for Nantes before joining St. Gallen in 2023, where he scored 14 league goals last season. Paris FC has large funds at its disposal since its takeover by France's richest family, the Arnaults of luxury empire LVMH. The energy drink giant Red Bull acquired a minority stake. Thursdays Keep up to date on sports with Mike McIntyre's weekly newsletter. For the first time in 35 years two Paris-based soccer clubs are in Ligue 1. Furthermore, Paris FC has changed its home stadium since being promoted and will play at Stade Jean-Bouin, which is literally across the street from defending champion Paris Saint-Germain's Parc des Princes stadium. ___ AP soccer:
Winnipeg Free Press
3 hours ago
- Winnipeg Free Press
US seeks shipbuilding expertise from South Korea and Japan to counter China
WASHINGTON (AP) — American lawmakers are using a trip to South Korea and Japan to explore how the United States can tap those allies' shipbuilding expertise and capacity to help boost its own capabilities, which are dwarfed by those of China. Sens. Tammy Duckworth, D-Ill., and Andy Kim, D-N.J., who are scheduled to land in Seoul on Sunday before traveling to Japan, plan to meet top shipbuilders from the world's second- and third-largest shipbuilding countries. The senators want to examine the possibilities of forming joint ventures to construct and repair noncombatant vessels for the U.S. Navy in the Indo-Pacific and bring investments to American shipyards. 'We already have fewer capacity now than we did during Operation Iraqi Freedom' in 2003, Duckworth told The Associated Press. 'We have to rebuild the capacity. At the same time, what capacity we have is aging and breaking down and taking longer and more expensive to fix.' Their trip comes as President Donald Trump demands a plan to revive U.S. shipyards and engage foreign partners. The Pentagon is seeking $47 billion for shipbuilding in its annual budget. The urgency stems from the fact that Washington severely lags behind China in building naval ships, a situation raising alarms among policymakers who worry the maritime balance of power could shift to China, now the world's No. 1 shipbuilder. Duckworth, who serves on the Senate Armed Services Committee, said she hopes the trip could lead to joint ventures among the U.S. military, American companies and foreign partners to build auxiliary vessels for the Navy and small boats for the Army. Another possibility is repairing U.S. ships in the Indo-Pacific region. 'If we have to bring ships all the way back to the United States … to wait two years to be fixed, that doesn't help the situation,' Duckworth said. The discussions, she said, will focus on auxiliary vessels, which are noncombatant ships such as fueling and cargo vessels that support naval and military operations. The Navy's auxiliary fleet is aging and insufficient in numbers, she said. The U.S. commercial shipbuilding accounted for 0.1% of global capacity in 2024, while China produced 53%, followed by South Korea and Japan, according to a report by the Center for Strategic and International Studies. A Navy review from April 2024 found that many of its major shipbuilding programs were one year to three years behind schedule. During the trip, the senators are expected to meet representatives from major shipbuilders in the region. Monday Mornings The latest local business news and a lookahead to the coming week. South Korea and the U.S. are already making progress on shipbuilding cooperation. In March, Hanwha Ocean completed maintenance work for a 41,000-ton U.S. Navy dry cargo and ammunition ship in South Korea. The overhaul of USNS Wally Schirra was the Korean company's first project after it secured a repair agreement with the U.S. Navy in July 2024. Hanwha Group last year acquired Philly Shipyard in Philadelphia, which builds large merchant mariners, part of the reserve auxiliary fleet. Earlier this month, South Korea proposed to invest $150 billion in the U.S. shipbuilding industry to support Trump's 'Make American Shipbuilding Great Again' initiative as part of its tariffs talk with the White House. Duckworth said she had earlier conversations with Hyundai Heavy Industries 'about them actually buying into U.S. shipyards on U.S. soil'. This month, China formed the world's biggest shipbuilding company by merging two state-owned shipbuilders. The combined entity China State Shipbuilding Corporation produces Chinese navy's combat vessels from aircraft carriers to nuclear submarines. It commands 21.5% of global shipbuilding market.
